Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole Dosing in Peptic Ulcer Bleeding
NCT00279123Phase 4Completed
- Sponsor
- Kwong Wah Hospital
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pantoprazole in Peptic ulcer hemorrhage (PUB) (3 arms), sponsored by Kwong Wah Hospital. Primary endpoint: Rebleeding rate within 30 days after endoscopic therapy. Started Jan 2002; status: completed.
02
Drugs
pantoprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT00279123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279123.